🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Sengetøjet indeholder azofarvestoffer, der frigiver de aromatiske aminer 4-chloranilin (målt koncentration op til 31 mg/kg) og 2,4-diaminotoluen (målt koncentration op til 95 mg/kg). Når produktet er i direkte og langvarig kontakt med huden, kan det aromatiske amin absorberes gennem huden. Aromatiske aminer kan forårsage kræft, cellemutationer og påvirke reproduktionen. Produktet overholder ikke REACH-forordningen.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Other
Category of measure
Recall of the product from end users
Date of entry into force
19/05/2015
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): The Amazing Spider-Man 2
Risk Description (original English): The bed linen contains azo dyes releasing the aromatic amines 4-Chloroaniline (measured concentration up to 31 mg/kg) and 2,4-Diaminotoluene (measured concentration up to 95 mg/kg). When the product is in direct and prolonged contact with the skin, the aromatic amine may be absorbed by the skin. Aromatic amines can cause cancer, cell mutations and affect reproduction.The product does not comply with the REACH Regulation.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.